Connect Biopharma Welcomes James Huang: Growth Surge Ahead by Mark Eisenberg 13.02.2024 Connect Biopharma has appointed James Zuie-chin Huang to its Board of Directors. Huang brings over 30 years of biotech experience ...
BioVaxys Acquires IMV’s Immunotherapy Tech for Growth by John Darbie 13.02.2024 BioVaxys Technology Corp. finalizes agreement to acquire IMV Inc.'s immunotherapy technology portfolio, expanding its cancer vaccine portfolio and positioning itself ...
YS Biopharma EGM Controversy: Shareholders in Revolt? by Mark Eisenberg 12.02.2024 YS Biopharma raises concerns about the validity of an extraordinary general meeting called by shareholders. The company also faces financial ...
Kintara’s REM-001: A Breakthrough in Breast Cancer Cure by Mark Eisenberg 12.02.2024 Kintara Therapeutics has launched a clinical trial for REM-001, a promising treatment for cutaneous metastatic breast cancer. The trial aims ...
Stock Shakeups: Diamondback Energy Merger, Air Taxis in Dubai, EV Tumbles by Mark Eisenberg 12.02.2024 Diamondback Energy and Endeavor Energy Resources are set to merge in a $26 billion deal, boosting Diamondback shares. Other companies ...
Tonix Pharma’s Potential PTSD Cure: A Game-Changer? by Mark Eisenberg 12.02.2024 Tonix Pharmaceuticals receives FDA clearance for its OASIS trial, evaluating the efficacy of TNX-102 SL in treating acute stress reactions ...
AN2 Therapeutics Pauses Trial: Efficacy Concerns Rise by Mark Eisenberg 12.02.2024 AN2 Therapeutics voluntarily pauses enrollment in its epetraborole clinical trial due to lower efficacy. Safety is not a concern. The ...
Oppenheimer Trims Gilead Sciences Price Target by Mark Eisenberg 12.02.2024 Oppenheimer lowers price target on Gilead Sciences after Q4 earnings report and challenges in drug pipeline. Optimistic about prospects for ...
Atossa Genetics: Potential Breakthrough in Breast Cancer? by Lilu Anderson 12.02.2024 Biopharmaceutical company Atossa Genetics receives Buy rating from H.C. Wainwright, with a new price target of $4.00. The company's promising ...
Tomorrow’s Top Stock Picks: Winners & Losers Revealed by Mark Eisenberg 12.02.2024 Discover the winners and losers in the stock market, including tech giants Microsoft and NVIDIA, as well as underperformers Intel ...